Bridgebio Pharma, Inc. · NASDAQ:BBIO
Bridgebio Pharma, Inc. shareholders
As of Jun 30, 2026, 460 institutions reported holding Bridgebio Pharma, Inc., 99.1% of its shares. Largest: Vanguard, Jupiter Topco LLC and Kohlberg Kravis Roberts & Co. L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Bridgebio Pharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 16.9M | 8.7% | −330K | Aug 13, 2026 |
| Jupiter Topco LLC | 14.1M | 7.2% | first report | Aug 14, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 13.3M | 6.8% | no change | Aug 14, 2026 |
| Farallon Capital Management, L.L.C. | 10.7M | 5.5% | +1.38M | Aug 14, 2026 |
| BlackRock | 10.3M | 5.3% | −3.92M | Aug 7, 2026 |
| Viking Global Investors LP | 9.95M | 5.1% | −1.89M | Aug 14, 2026 |
| Wellington | 5.31M | 2.7% | +2.82M | Aug 14, 2026 |
| Two Sigma | 4.74M | 2.4% | +1.62M | Aug 14, 2026 |
| Aisling Capital Management LP | 4.59M | 2.3% | −500K | Aug 13, 2026 |
| State Street | 4.44M | 2.3% | −498K | Aug 7, 2026 |